中医临床研究
中醫臨床研究
중의림상연구
CLINICAL JOURNAL OF CHINESE MEDICINE
2015年
18期
87-90
,共4页
姚君%王建尧%王立生%张茹%李迎雪%徐正磊
姚君%王建堯%王立生%張茹%李迎雪%徐正磊
요군%왕건요%왕립생%장여%리영설%서정뢰
溃疡性结肠炎%阿魏酸钠%NF-kB
潰瘍性結腸炎%阿魏痠鈉%NF-kB
궤양성결장염%아위산납%NF-kB
Ulcerative colitis%Sodium ferulate%NF-kB
目的:探讨阿魏酸钠(sodium ferulate, SF)对溃疡性结肠炎治疗的可能相关机制。方法:小鼠随机分4成组空白对照(NC)组、模型(MD)组、低剂量(SFLD)、高剂量(SFHD)阿魏酸钠治疗组,NC组采用正常饮用水饲养,采用5%葡聚糖硫酸钠(Dextran sulfate Sodium, DSS)制作UC小鼠模型,造模7 d成模后分为MD组、SFLD组和SFHD组,予药物干预治疗后续7 d。记录分析疾病活动指数(DAI)及脾脏指数(Spleen Index SI),取结肠组织行HE染色;Western blot检测结肠NF-KB表达水平;ELISA法测小鼠肠粘膜NF-kB活性。结果:SFLD组、SFHD组小鼠第8~14 d DAI明显低于MD组(P<0.05);SFLD组、SFHD组小鼠第14 d SI明显低于MD组(P<0.05);MD组SI明显高于NC组(P<0.05);SFLD组、SFHD组结肠NF-kB表达和活性明显低于MD组;MD组结肠NF-kB表达和活性明显高于NC组(P<0.05);MD组NF-kB表达和活性明显高于NC组(P<0.05)。结论:阿魏酸钠可以通过降低结肠NF-kB表达及活性;抑制脾脏代偿性增大,从而减轻肠道的炎症反应及抑制脾脏的免疫反应,改善UC全身炎症状态及免疫应答,对UC发挥治疗作用。
目的:探討阿魏痠鈉(sodium ferulate, SF)對潰瘍性結腸炎治療的可能相關機製。方法:小鼠隨機分4成組空白對照(NC)組、模型(MD)組、低劑量(SFLD)、高劑量(SFHD)阿魏痠鈉治療組,NC組採用正常飲用水飼養,採用5%葡聚糖硫痠鈉(Dextran sulfate Sodium, DSS)製作UC小鼠模型,造模7 d成模後分為MD組、SFLD組和SFHD組,予藥物榦預治療後續7 d。記錄分析疾病活動指數(DAI)及脾髒指數(Spleen Index SI),取結腸組織行HE染色;Western blot檢測結腸NF-KB錶達水平;ELISA法測小鼠腸粘膜NF-kB活性。結果:SFLD組、SFHD組小鼠第8~14 d DAI明顯低于MD組(P<0.05);SFLD組、SFHD組小鼠第14 d SI明顯低于MD組(P<0.05);MD組SI明顯高于NC組(P<0.05);SFLD組、SFHD組結腸NF-kB錶達和活性明顯低于MD組;MD組結腸NF-kB錶達和活性明顯高于NC組(P<0.05);MD組NF-kB錶達和活性明顯高于NC組(P<0.05)。結論:阿魏痠鈉可以通過降低結腸NF-kB錶達及活性;抑製脾髒代償性增大,從而減輕腸道的炎癥反應及抑製脾髒的免疫反應,改善UC全身炎癥狀態及免疫應答,對UC髮揮治療作用。
목적:탐토아위산납(sodium ferulate, SF)대궤양성결장염치료적가능상관궤제。방법:소서수궤분4성조공백대조(NC)조、모형(MD)조、저제량(SFLD)、고제량(SFHD)아위산납치료조,NC조채용정상음용수사양,채용5%포취당류산납(Dextran sulfate Sodium, DSS)제작UC소서모형,조모7 d성모후분위MD조、SFLD조화SFHD조,여약물간예치료후속7 d。기록분석질병활동지수(DAI)급비장지수(Spleen Index SI),취결장조직행HE염색;Western blot검측결장NF-KB표체수평;ELISA법측소서장점막NF-kB활성。결과:SFLD조、SFHD조소서제8~14 d DAI명현저우MD조(P<0.05);SFLD조、SFHD조소서제14 d SI명현저우MD조(P<0.05);MD조SI명현고우NC조(P<0.05);SFLD조、SFHD조결장NF-kB표체화활성명현저우MD조;MD조결장NF-kB표체화활성명현고우NC조(P<0.05);MD조NF-kB표체화활성명현고우NC조(P<0.05)。결론:아위산납가이통과강저결장NF-kB표체급활성;억제비장대상성증대,종이감경장도적염증반응급억제비장적면역반응,개선UC전신염증상태급면역응답,대UC발휘치료작용。
Objective:To investigate the mechanismof sodiumin the treatmentof ulcerative colitis. [Method] Mice were randomly divided i nto 4 groups:bl ank c ontrol (N C) , model group (MDgroup), lowdo se SF group(SFLD), high dos e SF group (SFHD). N C group with normal drinkingwater feeding, After 7 days of using5%dextran sulfate sodiumto make UC mouse model, the models with 7 days of drugi ntervention were divided into MDgroup, SFLD group and SFHD group. Re cord and a nalyze the di sease a ctivity index (DAI) and spleen index (Spleen Index SI), colon tissue were stained with HE;NF-KB expression of colon were detected by western blot;NF-kB a ctivity of intestinal mucosal were measured by E LISA. R esult:AmongSFLD group and SFHD group of mice on d ays 8-14, DAI was s ignificantly l ower than that of MDgroup ( P<0.05); AmongSFLD group and SFHD group of mice on 14 da ys, SI was significantly lower than thatof MD group(P<0.05);the SI of MD group was significantly higher than thatof group NC (P<0.05);AmongSFLD group and SFHD group, the expression and activity of NF-kB in colon was significantly lower than thatof MD group;the active of NF-kB expression in MD group was significantly higher than thatin NC group (P<0.05);the activity of NF-kB expression in MD group was higher than thatin NC group (P<0.05). Conclusion:Sodiumferulate can reduce the expression and activity of NF-kB of colon, inhibitthe s pleen’s c ompensatory increase, r elieve the i nflammatory r eaction of intestine,alleviate i mmune r eaction of s pleen,improve sy stemic inflammatory state and immune response of UC and play a role in the treatmentof UC.